Cogent Biosciences (COGT) EBIT Margin (2017 - 2020)
Cogent Biosciences' (COGT) quarterly EBIT Margin came in at 18333.01% in Q3 2020, down 1715301.0% year-on-year from N/an in Q4 2019, and down 1207.56% on a QoQ basis from 1402.08% in Q2 2020.
Cogent Biosciences (COGT) EBIT Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 4 years of EBIT Margin data on file, last reported at 18333.01% in Q3 2020.
- On a quarterly basis, EBIT Margin fell 1715301.0% year-over-year to 18333.01% in Q3 2020; TTM through Dec 2020 was 1044.33%, a 90131.0% decrease from a year earlier, with the FY2020 full-year figure at 1044.33%, down 90131.0% from the prior year.
- EBIT Margin for Q3 2020 stood at 18333.01%, down from 1402.08% in the prior quarter.
- Over the last five years, EBIT Margin for COGT reached as high as 14.65% in Q4 2019 and fell as low as 18333.01% in Q3 2020.
- Historically, EBIT Margin has averaged 1640.08% across 4 years, with a median of 332.18% in 2017.
- On a YoY basis, EBIT Margin climbed as much as 30051 bps in 2020 and fell as far as 1715301 bps in 2020.
- Year by year, EBIT Margin stood at 324.07% in 2017, then advanced by 27 bps to 236.64% in 2018, then surged by 106 bps to 14.65% in 2019, then plunged by 125223 bps to 18333.01% in 2020.
- Per Business Quant data, the three most recent EBIT Margin figures were 18333.01% in Q3 2020, 1402.08% in Q2 2020, and 87.34% in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -18,333.01% |
| Jun 30, 2020 | -1,402.08% |
| Mar 31, 2020 | -87.34% |
| Dec 31, 2019 | 14.65% |
| Sep 30, 2019 | -1,180.00% |
| Jun 30, 2019 | -335.91% |
| Mar 31, 2019 | -387.85% |
| Dec 31, 2018 | -236.64% |
| Sep 30, 2018 | -517.67% |
| Jun 30, 2018 | -566.57% |
| Mar 31, 2018 | -314.68% |
| Dec 31, 2017 | -324.07% |
| Sep 30, 2017 | -307.59% |
| Jun 30, 2017 | -290.19% |
| Mar 31, 2017 | -332.18% |